Loading...
Header Logo
Keywords
Last Name
Institution

LIN JI

TitleProfessor
InstitutionMD Anderson
DepartmentThoracic & Cardiovascular Surgery
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zhang B, Ji LH, Zhang CG, Zhao G, Wu ZY. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats. World J Gastroenterol. 2019 Oct 21; 25(39):5953-5960. PMID: 31660032.
      View in: PubMed
    2. Lin J, Ji L. Detection of MicroRNA-Mediated Target mRNA Cleavage and 3'-Uridylation in Human Cells by a SLA-RT-PCR Analysis. Methods Mol Biol. 2019; 1870:125-136. PMID: 30539551.
      View in: PubMed
    3. Raghavendra A, Wecsler J, Ji L, Sheth P, Ricker C, Church T, Sposto R, Lang J, Sener S, Larsen L, Tripathy D. Clinical findings and outcomes of MRI staging of breast cancer in a diverse population. Breast Cancer Res Treat. 2019 Apr; 174(2):315-324. PMID: 30542816.
      View in: PubMed
    4. Zhang B, Zhang CG, Ji LH, Zhao G, Wu ZY. Estrogen receptor ß selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. J Gastroenterol Hepatol. 2018 Mar; 33(3):747-755. PMID: 28884481.
      View in: PubMed
    5. Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg. 2018 06; 155(6):2635-2645.e15. PMID: 29548588.
      View in: PubMed
    6. Meraz IM, Majidi M, Cao X, Lin H, Li L, Wang J, Baladandayuthapani V, Rice D, Sepesi B, Ji L, Roth JA. TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer Immunol Res. 2018 02; 6(2):163-177. PMID: 29339375.
      View in: PubMed
    7. Cao X, Zhao Y, Wang J, Dai B, Gentile E, Lin J, Pu X, Ji L, Wu S, Meraz I, Majidi M, Roth JA. TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC). Oncotarget. 2017 Dec 08; 8(64):107621-107629. PMID: 29296193.
      View in: PubMed
    8. Zhang L, Lin J, Ye Y, Oba T, Gentile E, Lian J, Wang J, Zhao Y, Gu J, Wistuba II, Roth JA, Ji L, Wu X. Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1. Clin Pharmacol Ther. 2018 06; 103(6):1061-1073. PMID: 28891208.
      View in: PubMed
    9. Luo L, Zhou WH, Cai JJ, Feng M, Zhou M, Hu SP, Xu J, Ji LD. Gene Expression Profiling Identifies Downregulation of the Neurotrophin-MAPK Signaling Pathway in Female Diabetic Peripheral Neuropathy Patients. J Diabetes Res. 2017; 2017:8103904. PMID: 28900628.
      View in: PubMed
    10. Gentile E, Oba T, Lin J, Shao R, Meng F, Cao X, Lin HY, Mourad M, Pataer A, Baladandayuthapani V, Cai D, Roth JA, Ji L. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics. Oncotarget. 2017 Jul 18; 8(29):48222-48239. PMID: 28637023.
      View in: PubMed
    11. Xiaobo C, Majidi M, Feng M, Shao R, Wang J, Zhao Y, Baladandayuthapani V, Song J, Fang B, Ji L, Mehran R, Roth JA. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin. Sci Rep. 2016 11 15; 6:35741. PMID: 27845352.
      View in: PubMed
    12. Zhou M, Feng M, Fu LL, Ji LD, Zhao JS, Xu J. Toxicogenomic analysis identifies the apoptotic pathway as the main cause of hepatotoxicity induced by tributyltin. Food Chem Toxicol. 2016 Nov; 97:316-326. PMID: 27678064.
      View in: PubMed
    13. Xu K, Lin J, Zandi R, Roth JA, Ji L. MicroRNA-mediated target mRNA cleavage and 3'-uridylation in human cells. Sci Rep. 2016 07 21; 6:30242. PMID: 27440378.
      View in: PubMed
    14. Lin J, Xu K, Roth JA, Ji L. Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysis. Biochem Biophys Rep. 2016 Jul 01; 6:16-23. PMID: 26949742.
      View in: PubMed
    15. Liu F, Ding J, Wei W, Feng TT, Chen Y, Ji LH, Han YF. [Influence of GATA-1 on Expression of EpoR in Bone Marrow CD71+ Cells of Rat Model with High Altitude Polycythemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Jun; 24(3):884-91. PMID: 27342527.
      View in: PubMed
    16. Luo W, Ji LH, Geng H, Ma XJ, Xiong H, Yin QC, Yin YJ, Yu L, Ma J. [Clinical Therapeutic Efficacy of Rituximab Combined with Methotrexate on Primary Central Nervous System Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Apr; 24(2):444-7. PMID: 27151007.
      View in: PubMed
    17. Li H, Hu J, Wu S, Wang L, Cao X, Zhang X, Dai B, Cao M, Shao R, Zhang R, Majidi M, Ji L, Heymach JV, Wang M, Pan S, Minna J, Mehran RJ, Swisher SG, Roth JA, Fang B. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget. 2016 Jan 19; 7(3):3548-58. PMID: 26657290.
      View in: PubMed
    18. Xu J, Qian HX, Hu SP, Liu LY, Zhou M, Feng M, Su J, Ji LD. Gender-Specific Association of ATP2B1 Variants with Susceptibility to Essential Hypertension in the Han Chinese Population. Biomed Res Int. 2016; 2016:1910565. PMID: 26933664.
      View in: PubMed
    19. Dai B, Yan S, Lara-Guerra H, Kawashima H, Sakai R, Jayachandran G, Majidi M, Mehran R, Wang J, Bekele BN, Baladandayuthapani V, Yoo SY, Wang Y, Ying J, Meng F, Ji L, Roth JA. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy. PLoS One. 2015; 10(6):e0123967. PMID: 26053020.
      View in: PubMed
    20. Ji LD, Xu WN, Chai PF, Zheng W, Qian HX, Xu J. Polymorphisms in the CISH gene are associated with susceptibility to tuberculosis in the Chinese Han population. Infect Genet Evol. 2014 Dec; 28:240-4. PMID: 25460819.
      View in: PubMed
    21. Pan C, Han P, Ji L, Ji Q, Lu J, Lin J, Liu J, Su B, Shi J, Wang P. Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE study. J Diabetes. 2015 Mar; 7(2):222-30. PMID: 24909984.
      View in: PubMed
    22. Cai X, Han X, Zhang S, Luo Y, Chen Y, Ji L. Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS One. 2014; 9(3):e91174. PMID: 24614131.
      View in: PubMed
    23. Zhou L, Cai X, Han X, Ji L. P38 plays an important role in glucolipotoxicity-induced apoptosis in INS-1 cells. J Diabetes Res. 2014; 2014:834528. PMID: 24734256.
      View in: PubMed
    24. Wang A, Xu Z, Mu Y, Ji L. Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China. Int J Low Extrem Wounds. 2014 Mar; 13(1):17-21. PMID: 24659623.
      View in: PubMed
    25. Meng J, Majidi M, Fang B, Ji L, Bekele BN, Minna JD, Roth JA. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner. PLoS One. 2013; 8(10):e77067. PMID: 24146957.
      View in: PubMed
    26. Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging. 2013 Oct; 12(7):1-10. PMID: 23962694.
      View in: PubMed
    27. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013; 8(8):e71108. PMID: 24013136.
      View in: PubMed
    28. Xiao J, Weng J, Ji L, Jia W, Lu J, Shan Z, Liu J, Tian H, Ji Q, Yang Z, Yang W. Worse pancreatic ß-cell function and better insulin sensitivity in older Chinese without diabetes. J Gerontol A Biol Sci Med Sci. 2014 Apr; 69(4):463-70. PMID: 23974206.
      View in: PubMed
    29. Kong X, Hong J, Chen Y, Chen L, Zhao Z, Li Q, Ge J, Chen G, Guo X, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Zhou Z, Shan G, Yang W. Association of genetic variants with isolated fasting hyperglycaemia and isolated postprandial hyperglycaemia in a Han Chinese population. PLoS One. 2013; 8(8):e71399. PMID: 23990951.
      View in: PubMed
    30. Zhang B, Ji LH, Liu W, Zhao G, Wu ZY. Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression. World J Gastroenterol. 2013 Aug 14; 19(30):4917-24. PMID: 23946596.
      View in: PubMed
    31. Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M, Bertolone S, Cornelius A, Gardner S, Patel R, Pradhan K, Shen V, Thompson S, Torkildson J, Sposto R, Finlay JL. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer. 2014 Jan; 61(1):95-101. PMID: 23934933.
      View in: PubMed
    32. Dai B, Yoo SY, Bartholomeusz G, Graham RA, Majidi M, Yan S, Meng J, Ji L, Coombes K, Minna JD, Fang B, Roth JA. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer. Cancer Res. 2013 Sep 01; 73(17):5532-43. PMID: 23824739.
      View in: PubMed
    33. Ji L, Li H, Guo X, Li Y, Hu R, Zhu Z. Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial. PLoS One. 2013; 8(2):e57222. PMID: 23468941.
      View in: PubMed
    34. Ji L, Tong X, Wang H, Tian H, Zhou H, Zhang L, Li Q, Wang Y, Li H, Liu M, Yang H, Gao Y, Li Y, Li Q, Guo X, Yang G, Zhang Z, Zhou Z, Ning G, Chen Y, Paul S. Efficacy and safety of traditional chinese medicine for diabetes: a double-blind, randomised, controlled trial. PLoS One. 2013; 8(2):e56703. PMID: 23460810.
      View in: PubMed
    35. Han X, Luo Y, Zhang X, Lv C, Sun X, Zhang X, Zhou X, Cai X, Ren Q, Ji L. Rs4074134 near BDNF gene is associated with type 2 diabetes mellitus in Chinese Han population independently of body mass index. PLoS One. 2013; 8(2):e56898. PMID: 23431394.
      View in: PubMed
    36. Zhang LN, Ji LD, Fei LJ, Yuan F, Zhang YM, Xu J. Association between polymorphisms of alpha-adducin gene and essential hypertension in Chinese population. Biomed Res Int. 2013; 2013:451094. PMID: 23509723.
      View in: PubMed
    37. Yuan F, Xu J, Ji LD, Fei LJ, Liu PP, Zhang LN. [Application of Tm-shift genotyping method in genetic studies]. Yi Chuan. 2012 Nov; 34(11):1484-90. PMID: 23208146.
      View in: PubMed
    38. Ji LD, Chai PF, Zhou BB, Tang NL, Xing WH, Yuan F, Fei LJ, Zhang LN, Xu J. Lack of association between polymorphisms from genome-wide association studies and tuberculosis in the Chinese population. Scand J Infect Dis. 2013 Apr; 45(4):310-4. PMID: 23113532.
      View in: PubMed
    39. Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, Yang L, Lin J, Liu Z, Hagopian WA, Leslie RD. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes. 2013 Feb; 62(2):543-50. PMID: 23086039.
      View in: PubMed
    40. Huschka R, Barhoumi A, Liu Q, Roth JA, Ji L, Halas NJ. Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA. ACS Nano. 2012 Sep 25; 6(9):7681-91. PMID: 22862291.
      View in: PubMed
    41. Ji LD, Qiu YQ, Xu J, Irwin DM, Tam SC, Tang NL, Zhang YP. Genetic adaptation of the hypoxia-inducible factor pathway to oxygen pressure among eurasian human populations. Mol Biol Evol. 2012 Nov; 29(11):3359-70. PMID: 22628534.
      View in: PubMed
    42. Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One. 2012; 7(4):e34833. PMID: 22558101.
      View in: PubMed
    43. Correa-Fernández V, Ji L, Castro Y, Heppner WL, Vidrine JI, Costello TJ, Mullen PD, Cofta-Woerpel L, Velasquez MM, Greisinger A, Cinciripini PM, Wetter DW. Mediators of the association of major depressive syndrome and anxiety syndrome with postpartum smoking relapse. J Consult Clin Psychol. 2012 Aug; 80(4):636-48. PMID: 22390410.
      View in: PubMed
    44. Fei LJ, Ji LD, Zhang LN, Hua S, Jin JQ, Xu J. [Application of SNPstream for medical genetics research]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Feb; 29(1):9-12. PMID: 22311482.
      View in: PubMed
    45. Ji L, Jayachandran G, Roth JA. High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platform. Methods Mol Biol. 2012; 818:199-216. PMID: 22083825.
      View in: PubMed
    46. Jayachandran G, Roth JA, Ji L. Analysis of protein-protein interaction using proteinchip array-based SELDI-TOF mass spectrometry. Methods Mol Biol. 2012; 818:217-26. PMID: 22083826.
      View in: PubMed
    47. Zandi R, Xu K, Poulsen HS, Roth JA, Ji L. The effect of adenovirus-mediated gene expression of FHIT in small cell lung cancer cells. Cancer Invest. 2011 Dec; 29(10):683-91. PMID: 22085272.
      View in: PubMed
    48. Cai YL, Cui S, Li ZQ, Wang HX, Ji LH, Chai KX. [Studies on apoptosis and caspase-8 and caspase-9 expressions of bone marrow cells in chronic mountain sickness]. Zhonghua Xue Ye Xue Za Zhi. 2011 Nov; 32(11):762-5. PMID: 22339913.
      View in: PubMed
    49. Mei YP, Liao JP, Shen J, Yu L, Liu BL, Liu L, Li RY, Ji L, Dorsey SG, Jiang ZR, Katz RL, Wang JY, Jiang F. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012 May 31; 31(22):2794-804. PMID: 21986946.
      View in: PubMed
    50. Kim MP, Chen Y, Bekele BN, Lopez A, Khanna A, Chen JQ, Spitz MR, Behrens C, Solis L, Wismach M, Ji L, Wistuba II, Roth JA, Katz RL. Activating enhancer-binding protein-2ß nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50. PMID: 21871297.
      View in: PubMed
    51. Heppner WL, Ji L, Reitzel LR, Reitzel L, Castro Y, Correa-Fernandez V, Vidrine JI, Li Y, Dolan-Mullen P, Velasquez MM, Cinciripini PM, Cinciripini P, Cofta-Woerpel L, Cofta-Woerpel L, Greisinger A, Wetter D. The role of prepartum motivation in the maintenance of postpartum smoking abstinence. Health Psychol. 2011 Nov; 30(6):736-45. PMID: 21859215.
      View in: PubMed
    52. Lin J, Xu K, Gitanjali J, Roth JA, Ji L. Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells. Biochem Biophys Res Commun. 2011 Jul 01; 410(2):235-41. PMID: 21645495.
      View in: PubMed
    53. Dai B, Meng J, Peyton M, Girard L, Bornmann WG, Ji L, Minna JD, Fang B, Roth JA. STAT3 mediates resistance to MEK inhibitor through microRNA miR-17. Cancer Res. 2011 May 15; 71(10):3658-68. PMID: 21444672.
      View in: PubMed
    54. Li G, Kawashima H, Ji L, Ogose A, Ariizumi T, Umezu H, Xu Y, Hotta T, Endo N. Frequent absence of tumor suppressor FUS1 protein expression in human bone and soft tissue sarcomas. Anticancer Res. 2011 Jan; 31(1):11-21. PMID: 21273575.
      View in: PubMed
    55. Singh SP, Han L, Murali R, Solis L, Roth J, Ji L, Wistuba I, Kundra V. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Hum Gene Ther. 2011 Jan; 22(1):55-64. PMID: 20653396.
      View in: PubMed
    56. Motomura T, Ueda K, Ohtani S, Hansen E, Ji L, Ito K, Saito K, Sugita Y, Nosé Y. Evaluation of systemic external microwave hyperthermia for treatment of pleural metastasis in orthotopic lung cancer model. Oncol Rep. 2010 Sep; 24(3):591-8. PMID: 20664962.
      View in: PubMed
    57. Jayachandran G, Ueda K, Wang B, Roth JA, Ji L. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. PLoS One. 2010 Aug 05; 5(8):e11994. PMID: 20700484.
      View in: PubMed
    58. Ji LD, Zhang LN, Shen P, Wang P, Zhang YM, Xing WH, Xu J. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis. J Hypertens. 2010 Mar; 28(3):419-28. PMID: 20087216.
      View in: PubMed
    59. Ji LD, Xu J, Wu DD, Xie SD, Tang NL, Zhang YP. Association of disease-predisposition polymorphisms of the melatonin receptors and sunshine duration in the global human populations. J Pineal Res. 2010 Mar; 48(2):133-41. PMID: 20050988.
      View in: PubMed
    60. Meng J, Peng H, Dai B, Guo W, Wang L, Ji L, Minna JD, Chresta CM, Smith PD, Fang B, Roth JA. High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886). Cancer Biol Ther. 2009 Nov; 8(21):2073-80. PMID: 19783898.
      View in: PubMed
    61. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 2009 Aug; 7(8):1234-43. PMID: 19671678.
      View in: PubMed
    62. Moghaddam SJ, Li H, Cho SN, Dishop MK, Wistuba II, Ji L, Kurie JM, Dickey BF, Demayo FJ. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol. 2009 Apr; 40(4):443-53. PMID: 18927348.
      View in: PubMed
    63. Ji L, Roth JA. Tumor suppressor FUS1 signaling pathway. J Thorac Oncol. 2008 Apr; 3(4):327-30. PMID: 18379348.
      View in: PubMed
    64. Yang Y, Wislez M, Fujimoto N, Prudkin L, Izzo JG, Uno F, Ji L, Hanna AE, Langley RR, Liu D, Johnson FM, Wistuba I, Kurie JM. A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Mol Cancer Ther. 2008 Apr; 7(4):952-60. PMID: 18413809.
      View in: PubMed
    65. Bankson JA, Ji L, Ravoori M, Han L, Kundra V. Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging. 2008 Jan; 27(1):57-62. PMID: 18058933.
      View in: PubMed
    66. Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, Minna JD, Moran C, Roth JA, Ji L, Wistuba II. Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res. 2008 Jan 01; 14(1):41-7. PMID: 18172250.
      View in: PubMed
    67. Jayachandran G, Sazaki J, Nishizaki M, Xu K, Girard L, Minna JD, Roth JA, Ji L. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch. Cancer Res. 2007 Nov 01; 67(21):10379-88. PMID: 17974981.
      View in: PubMed
    68. Deng WG, Wu G, Ueda K, Xu K, Roth JA, Ji L. Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1. Cancer Gene Ther. 2008 Jan; 15(1):29-39. PMID: 17828283.
      View in: PubMed
    69. Deng WG, Jayachandran G, Wu G, Xu K, Roth JA, Ji L. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. J Biol Chem. 2007 Sep 07; 282(36):26460-70. PMID: 17630431.
      View in: PubMed
    70. Ohtani S, Iwamaru A, Deng W, Ueda K, Wu G, Jayachandran G, Kondo S, Atkinson EN, Minna JD, Roth JA, Ji L. Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy. Cancer Res. 2007 Jul 01; 67(13):6293-303. PMID: 17616688.
      View in: PubMed
    71. Lin J, Sun T, Ji L, Deng W, Roth J, Minna J, Arlinghaus R. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1. Oncogene. 2007 Oct 25; 26(49):6989-96. PMID: 17486070.
      View in: PubMed
    72. Deng WG, Nishizaki M, Fang B, Roth JA, Ji L. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells. Biochem Biophys Res Commun. 2007 Apr 20; 355(4):993-9. PMID: 17328863.
      View in: PubMed
    73. Ma SL, Tang NL, Zhang YP, Ji LD, Tam CW, Lui VW, Chiu HF, Lam LC. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese. Neurobiol Aging. 2008 Jun; 29(6):856-60. PMID: 17234302.
      View in: PubMed
    74. Deng WG, Kawashima H, Wu G, Jayachandran G, Xu K, Minna JD, Roth JA, Ji L. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res. 2007 Jan 15; 67(2):709-17. PMID: 17234782.
      View in: PubMed
    75. Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res. 2006 Oct 01; 66(19):9682-90. PMID: 17018626.
      View in: PubMed
    76. Dong F, Wang L, Davis JJ, Hu W, Zhang L, Guo W, Teraishi F, Ji L, Fang B. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus. Clin Cancer Res. 2006 Sep 01; 12(17):5224-30. PMID: 16951242.
      View in: PubMed
    77. Xu J, Ji LD, Xu LH. Lead-induced apoptosis in PC 12 cells: involvement of p53, Bcl-2 family and caspase-3. Toxicol Lett. 2006 Oct 10; 166(2):160-7. PMID: 16887300.
      View in: PubMed
    78. Davis JJ, Wang L, Dong F, Zhang L, Guo W, Teraishi F, Xu K, Ji L, Fang B. Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter. Cancer Gene Ther. 2006 Jul; 13(7):720-3. PMID: 16485010.
      View in: PubMed
    79. Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol. 2005 Feb; 1(1):79-92. PMID: 16555978.
      View in: PubMed
    80. Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD, Xu K, Atkinson EN, Bekele BN, Stephens LC, Minna JD, Roth JA, Ramesh R. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther. 2004 Nov; 11(11):733-9. PMID: 15486560.
      View in: PubMed
    81. Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. J Natl Cancer Inst. 2004 Oct 20; 96(20):1536-48. PMID: 15494604.
      View in: PubMed
    82. Nishizaki M, Sasaki J, Fang B, Atkinson EN, Minna JD, Roth JA, Ji L. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells. Cancer Res. 2004 Aug 15; 64(16):5745-52. PMID: 15313915.
      View in: PubMed
    83. Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN, Kondo M, Minna JD, Roth JA, Ji L. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res. 2004 May 01; 64(9):2969-76. PMID: 15126327.
      View in: PubMed
    84. Lin T, Gu J, Zhang L, Davis JJ, Huang X, Cabbini G, Ji L, Fang B. Enhancing adenovirus-mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone. J Gene Med. 2003 Oct; 5(10):868-875. PMID: 14533195.
      View in: PubMed
    85. Lin T, Zhang L, Davis J, Gu J, Nishizaki M, Ji L, Roth JA, Xiong M, Fang B. Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Mol Ther. 2003 Sep; 8(3):441-8. PMID: 12946317.
      View in: PubMed
    86. Carboni GL, Gao B, Nishizaki M, Xu K, Minna JD, Roth JA, Ji L. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene. 2003 Jan 30; 22(4):615-26. PMID: 12555074.
      View in: PubMed
    87. Gu J, Zhang L, Huang X, Lin T, Yin M, Xu K, Ji L, Roth JA, Fang B. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene. 2002 Jul 18; 21(31):4757-64. PMID: 12101414.
      View in: PubMed
    88. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, Minna JD. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 2002 May 01; 62(9):2715-20. PMID: 11980673.
      View in: PubMed
    89. Kondo M, Ji L, Kamibayashi C, Tomizawa Y, Randle D, Sekido Y, Yokota J, Kashuba V, Zabarovsky E, Kuzmin I, Lerman M, Roth J, Minna JD. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene. 2001 Sep 27; 20(43):6258-62. PMID: 11593436.
      View in: PubMed
    90. Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA, Ji L. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res. 2001 Sep; 7(9):2887-97. PMID: 11555607.
      View in: PubMed
    91. Ramesh R, Saeki T, Templeton NS, Ji L, Stephens LC, Ito I, Wilson DR, Wu Z, Branch CD, Minna JD, Roth JA. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther. 2001 Mar; 3(3):337-50. PMID: 11273776.
      View in: PubMed
    92. Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene. 2000 Sep 07; 19(38):4432-6. PMID: 10980619.
      View in: PubMed
    93. Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment. Am J Respir Cell Mol Biol. 2000 Sep; 23(3):297-303. PMID: 10970819.
      View in: PubMed
    94. Wang Y, Zhou Q, Liu J, Zhang W, Jing H, Liu L, Chen J. [Transcriptional expression of apoptosis suppression gene bcl-2 in non-small cell lung carcinoma]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000 Aug; 17(4):262-5. PMID: 10932011.
      View in: PubMed
    95. Kagawa S, Gu J, Swisher SG, Ji L, Roth JA, Lai D, Stephens LC, Fang B. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res. 2000 Mar 01; 60(5):1157-61. PMID: 10728665.
      View in: PubMed
    96. Kagawa S, Pearson SA, Ji L, Xu K, McDonnell TJ, Swisher SG, Roth JA, Fang B. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther. 2000 Jan; 7(1):75-9. PMID: 10680019.
      View in: PubMed
    97. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 1999 Jul 15; 59(14):3333-9. PMID: 10416589.
      View in: PubMed
    98. Ji L, Fang B, Roth JA. A rapid, sensitive, and nonradioactive method for assay of FHIT Ap3A hydrolase activity by fluorescence thin-layer chromatographic image analysis. Anal Biochem. 1999 Jun 15; 271(1):114-6. PMID: 10361018.
      View in: PubMed
    99. Ji L, Bouvet M, Price RE, Roth JA, Fang B. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Gene Ther. 1999 Mar; 6(3):393-402. PMID: 10435089.
      View in: PubMed
    100. Fang B, Ji L, Bouvet M, Roth JA. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery. J Biol Chem. 1998 Feb 27; 273(9):4972-5. PMID: 9478943.
      View in: PubMed
    101. Bouvet M, Fang B, Ekmekcioglu S, Ji L, Bucana CD, Hamada K, Grimm EA, Roth JA. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide. Gene Ther. 1998 Feb; 5(2):189-95. PMID: 9578838.
      View in: PubMed
    102. Fang B, Koch P, Bouvet M, Ji L, Roth JA. A packaging system for SV40 vectors without viral coding sequences. Anal Biochem. 1997 Dec 01; 254(1):139-43. PMID: 9398356.
      View in: PubMed
    103. Ji L, Becana M, Sarath G, Klucas RV. Cloning and sequence analysis of a cDNA encoding ferric leghemoglobin reductase from soybean nodules. Plant Physiol. 1994 Feb; 104(2):453-9. PMID: 8159785.
      View in: PubMed
    104. Ji L, Becana M, Klucas RV. Involvement of Molecular Oxygen in the Enzyme-Catalyzed NADH Oxidation and Ferric Leghemoglobin Reduction. Plant Physiol. 1992 Sep; 100(1):33-9. PMID: 16652965.
      View in: PubMed
    105. Ji L, Wood S, Becana M, Klucas RV. Purification and characterization of soybean root nodule ferric leghemoglobin reductase. Plant Physiol. 1991 May; 96(1):32-7. PMID: 16668174.
      View in: PubMed
    106. Becana M, Salin ML, Ji L, Klucas RV. Flavin-mediated reduction of ferric leghemoglobin from soybean nodules. Planta. 1991 Mar; 183(4):575-83. PMID: 24193851.
      View in: PubMed
    107. Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysis. Biochemistry and Biophysics Reports. 6:16-23.
    108. 3p21.3 tumor suppressor cluster. Future Oncology. 1:79-92.
    109. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells. Oncotarget. 7:3548-3558.
    110. Exogenous restoration of TUSC2 expression induces responsiveness to erlotinib in wildtype epidermal growth factor receptor (EGFR) lung cancer cells through context specific pathways resulting in enhanced therapeutic efficacy. PLoS One. 10.
    111. Scientific Reports. 6.
    112. Overproduction in Escherichia coli and characterization of a soybean ferric leghemoglobin reductase. Plant Physiology. 106:203-209.
    113. Establishing a GMP manufacturing site for nanoparticles. 413-416.
    114. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin. Scientific Reports. 6.
    JI's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description